Holen Sie sich die Stockscreener-App
88.90
0.77%
-0.77
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$89.67
Offen:
$89.65
24-Stunden-Volumen:
5.63M
Relative Volume:
0.41
Marktkapitalisierung:
$268.80B
Einnahmen:
$128.92B
Nettoeinkommen (Verlust:
$22.97B
KGV:
12.92
EPS:
6.8796
Netto-Cashflow:
$-2.35B
1W Leistung:
-0.24%
1M Leistung:
+1.67%
6M Leistung:
+13.64%
1J Leistung:
+10.81%
1-Tages-Spanne:
$88.67
$89.99
1-Wochen-Bereich:
$87.20
$90.13
52-Wochen-Spanne:
$72.78
$97.76
Wells Fargo Co Stock (WFC) Company Profile
Firmenname
Wells Fargo Co
Sektor
Branche
Telefon
(800) 869-3557
Adresse
333 MARKET STREET, SAN FRANCISCO, CA
Compare WFC vs JPM, BAC, HSBC, RY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
WFC
Wells Fargo Co
|
88.89 | 271.16B | 128.92B | 22.97B | -2.35B | 6.8796 |
JPM
Jpmorgan Chase Co
|
352.57 | 942.89B | 297.42B | 64.78B | 148.32B | 23.34 |
BAC
Bank Of America Corp
|
62.25 | 438.24B | 194.43B | 33.77B | 64.54B | 4.3483 |
HSBC
Hsbc Holdings Plc Adr
|
103.60 | 359.98B | 133.80B | 21.76B | 105.99B | 6.0511 |
RY
Royal Bank Of Canada
|
206.06 | 286.31B | 99.69B | 16.04B | 26.84B | 11.15 |
Wells Fargo Co Stock (WFC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-01 | Hochstufung | HSBC Securities | Hold → Buy |
| 2026-03-26 | Eingeleitet | Jefferies | Buy |
| 2026-02-13 | Hochstufung | Robert W. Baird | Underperform → Neutral |
| 2026-01-06 | Herabstufung | Robert W. Baird | Neutral → Underperform |
| 2025-09-29 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-07-07 | Herabstufung | Raymond James | Strong Buy → Mkt Perform |
| 2025-05-15 | Eingeleitet | TD Cowen | Hold |
| 2025-04-08 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2025-03-13 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-10-08 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2024-09-06 | Bestätigt | Evercore ISI | Outperform |
| 2024-09-03 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-04-09 | Herabstufung | Compass Point | Buy → Neutral |
| 2024-03-27 | Herabstufung | Keefe Bruyette | Outperform → Mkt Perform |
| 2024-01-18 | Herabstufung | Odeon | Buy → Hold |
| 2024-01-09 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2024-01-08 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2023-12-14 | Hochstufung | Odeon | Hold → Buy |
| 2023-09-07 | Eingeleitet | HSBC Securities | Hold |
| 2023-07-17 | Herabstufung | Odeon | Buy → Hold |
| 2023-07-07 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2023-07-03 | Bestätigt | Raymond James | Strong Buy |
| 2023-06-08 | Herabstufung | Odeon | Buy → Hold |
| 2023-04-06 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-03-13 | Herabstufung | Odeon | Buy → Hold |
| 2023-01-17 | Herabstufung | Jefferies | Buy → Hold |
| 2023-01-17 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-01-10 | Hochstufung | Odeon | Hold → Buy |
| 2022-10-03 | Hochstufung | Goldman | Neutral → Buy |
| 2022-04-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-02-01 | Hochstufung | Atlantic Equities | Neutral → Overweight |
| 2022-01-12 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-01-03 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2021-12-10 | Fortgesetzt | UBS | Buy |
| 2021-12-06 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-11-29 | Hochstufung | Odeon | Hold → Buy |
| 2021-09-28 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-19 | Herabstufung | Odeon | Buy → Hold |
| 2021-07-15 | Hochstufung | Odeon | Hold → Buy |
| 2021-07-07 | Fortgesetzt | Keefe Bruyette | Outperform |
| 2021-06-04 | Hochstufung | BofA Securities | Neutral → Buy |
| 2021-05-19 | Herabstufung | UBS | Buy → Neutral |
| 2021-02-18 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2021-01-25 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2021-01-19 | Hochstufung | Seaport Global Securities | Neutral → Buy |
| 2021-01-12 | Hochstufung | UBS | Neutral → Buy |
| 2021-01-07 | Hochstufung | Jefferies | Hold → Buy |
| 2020-12-29 | Bestätigt | Raymond James | Outperform |
| 2020-12-15 | Hochstufung | Keefe Bruyette | Mkt Perform → Outperform |
| 2020-11-30 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-11-30 | Hochstufung | RBC Capital Mkts | Underperform → Sector Perform |
| 2020-11-24 | Hochstufung | Raymond James | Underperform → Outperform |
| 2020-11-19 | Hochstufung | DA Davidson | Neutral → Buy |
| 2020-11-06 | Hochstufung | Compass Point | Neutral → Buy |
| 2020-09-14 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-09-11 | Hochstufung | UBS | Sell → Neutral |
| 2020-09-02 | Hochstufung | Odeon | Hold → Buy |
| 2020-07-22 | Hochstufung | Atlantic Equities | Underweight → Neutral |
| 2020-07-15 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2020-07-10 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-07-09 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2020-07-08 | Eingeleitet | Seaport Global Securities | Neutral |
| 2020-06-04 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-05-29 | Eingeleitet | DA Davidson | Neutral |
| 2020-05-05 | Herabstufung | Atlantic Equities | Neutral → Underweight |
| 2020-05-04 | Herabstufung | UBS | Neutral → Sell |
| 2020-04-14 | Eingeleitet | Compass Point | Neutral |
| 2020-03-26 | Hochstufung | Odeon | Sell → Hold |
Alle ansehen
Wells Fargo Co Aktie (WFC) Neueste Nachrichten
Disc Medicine at Wells Fargo conference: two drug bets near key tests - Investing.com
Spyre Therapeutics at Wells Fargo conference: betting on combination biologics - Investing.com UK
Eagle Materials (NYSE:EXP) Downgraded by Wells Fargo & Company to Hold - MarketBeat
Thermo Fisher, Wells Fargo, Nutrien And More On CNBC’s ‘Final Trades’ - Benzinga
Wells Fargo cuts Cooper Companies stock price target on guidance miss - Investing.com Canada
Wells Fargo cuts Kimberly-Clark stock price target on earnings concerns - Investing.com
Wells Fargo cuts AutoZone stock price target on earnings concerns - Investing.com
Wells Fargo cuts Casey’s General Stores price target on valuation - Investing.com
Wells Fargo cuts AutoZone stock price target on earnings concerns By Investing.com - Investing.com UK
Wells Fargo upgrades Yum! Brands stock rating on growth outlook By Investing.com - Investing.com India
Wells Fargo raises RXO stock price target on brokerage momentum By Investing.com - Investing.com India
WINTON GROUP Ltd Acquires New Holdings in Wells Fargo & Company $WFC - MarketBeat
Wells Fargo cuts Core & Main stock price target on margin concerns - Investing.com Canada
Wells Fargo cuts Casey’s General Stores price target on valuation By Investing.com - Investing.com Canada
Wells Fargo raises Pyxis Oncology stock price target on MICVO data - Investing.com India
Wells Fargo raises Signet Jewelers stock price target on credit deal - Investing.com UK
Wells Fargo raises Academy Sports stock price target on diversified product mix - Investing.com India
Pharvaris at Wells Fargo conference: oral HAE drug gains ground By Investing.com - Investing.com Nigeria
ORIC Pharmaceuticals at Wells Fargo conference: late-stage pipeline in focus - Investing.com India
Halozyme at Wells Fargo healthcare conference: subQ push gains steam By Investing.com - Investing.com Canada
Climb Bio at Wells Fargo conference: two antibody bets draw focus - Investing.com India
Rhythm Pharmaceuticals at Wells Fargo conference: ho launch gains traction - Investing.com
ThredUp to Participate in Goldman Sachs and Wells Fargo Conferences - GlobeNewswire
AptarGroup at Wells Fargo healthcare conference: execution takes center stage - Investing.com
UnitedHealth Group (NYSE: UNH) Shares Strategic Insights and Performance at Wells Fargo Healthcare Conference - Kalkine Media
Becton, Dickinson at Wells Fargo healthcare conference: focus sharpens - Investing.com
Final Trades: Wells Fargo, Thermo Fisher, Nutrien and the INFL - CNBC
Ardent Health at wells fargo healthcare conference: margin push gains pace - Investing.com UK
VMC Downgraded by Wells Fargo -- Price Target Lowered to $254 - GuruFocus
Watch CNBC's full interview with Wells Fargo CEO, Charlie Scharf - CNBC
Regeneron at Wells Fargo healthcare conference: growth broadens By Investing.com - Investing.com UK
Kiniksa at Wells Fargo conference: arcalyst growth and pipeline deepen - Investing.com
Kiniksa at Wells Fargo conference: arcalyst growth and pipeline deepen By Investing.com - Investing.com India
Wells Fargo raises Pharvaris stock price target on strong trial data - Investing.com
Wells Fargo cuts ServiceTitan stock price target on Max adoption - Investing.com
Wells Fargo raises Paychex stock price target on float income outlook - Investing.com Canada
Wells Fargo & Co. stock eases below analyst targets after recent pullback - ad-hoc-news.de
Wells Fargo stock heads into the open after a 2.23% drop - ad-hoc-news.de
Biz Groups Ask 8th Circ. To Nix Wells Fargo ERISA Suit - law360.com
Kura Oncology at Wells Fargo conference: launch gains and pipeline breadth - Investing.com
Vaxcyte at Wells Fargo conference: broader vaccines, bigger stakes By Investing.com - Investing.com Canada
Vaxcyte at Wells Fargo conference: broader vaccines, bigger stakes - Investing.com India
Medtronic Diabetes at Wells Fargo conference: product wave drives growth - Investing.com
Nurix Therapeutics at Wells Fargo conference: pipeline, deal momentum - Investing.com
Nurix Therapeutics at Wells Fargo conference: pipeline, deal momentum By Investing.com - Investing.com UK
Wells Fargo (NYSE:WFC): Does the Asset-Cap Removal Still Matter as Rate-Hike Odds Climb? - Kalkine Media
Milestone Pharmaceuticals at Wells Fargo: launch gains, bigger test ahead - Investing.com
Beam Therapeutics at Wells Fargo conference: base editing gains ground By Investing.com - Investing.com Canada
Milestone Pharmaceuticals at Wells Fargo: launch gains, bigger test ahead By Investing.com - Investing.com UK
Wells Fargo & Co. stock edges lower as Q2 2026 earnings beat and dividend hike set the tone - ad-hoc-news.de
Celcuity at Wells Fargo healthcare conference: launch, data in focus - Investing.com
Finanzdaten der Wells Fargo Co-Aktie (WFC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.93%
0.29%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):